# Immunic, Inc.: filings

IMUX · Nasdaq · CIK 1280776 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imux.md) · [Financials](/companies/imux/financials.md) · [Filings](/companies/imux/filings.md) · [Insiders](/companies/imux/insiders.md)

## Reports and events: 272 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 257, 8-K 177, 3 44, 10-Q 38, SC 13G/A 26, SCHEDULE 13G/A 24, 424B5 21, SC 13G 21, CORRESP 20, D/A 14, DEF 14A 14, S-8 14, SCHEDULE 13G 14, UPLOAD 14, 10-K 12, EFFECT 11, D 10, DEFA14A 9, S-1/A 8, S-3 8, SC 13D/A 8, 425 7, 4/A 6, SC 13D 6, FWP 5, 5 4, S-3/A 4, 424B3 3, 8-K/A 3, 10-K/A 2, 3/A 2, 424B4 2, DRSLTR 2, PRE 14A 2, S-1 2, SEC STAFF LETTER 2, 10-Q/A 1, 8-A12B 1, ARS 1, CERTNAS 1, DRS 1, DRS/A 1, S-4 1, S-4/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 17:24 ET | [8-K](/filings/0001193805-26-001219.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-001219 |
| 2026-09-09 | 09:01 ET | [8-K](/filings/0001193805-26-001196.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001196 |
| 2026-08-11 | 07:05 ET | [8-K](/filings/0001193805-26-001071.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001071 |
| 2026-08-11 | 06:59 ET | [10-Q](/filings/0001280776-26-000018.md) | Quarterly report, period 2026-06-30 | 0001280776-26-000018 |
| 2026-07-14 | 08:01 ET | [8-K](/filings/0001193805-26-000966.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000966 |
| 2026-07-06 | 16:22 ET | [8-K](/filings/0001193805-26-000916.md) | 5.02 Departure or appointment of officers or directors | 0001193805-26-000916 |
| 2026-06-29 | 16:05 ET | [8-K](/filings/0001193805-26-000882.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-26-000882 |
| 2026-05-29 | 16:33 ET | [DEF 14A](/filings/0001193805-26-000719.md) | Proxy statement, period 2026-06-29 | 0001193805-26-000719 |
| 2026-05-28 | 07:01 ET | [8-K](/filings/0001193805-26-000703.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000703 |
| 2026-05-27 | 07:00 ET | [8-K](/filings/0001193805-26-000696.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000696 |
| 2026-05-19 | 07:00 ET | [8-K](/filings/0001193805-26-000645.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000645 |
| 2026-05-13 | 07:01 ET | [8-K](/filings/0001193805-26-000593.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000593 |
| 2026-05-13 | 06:36 ET | [10-Q](/filings/0001280776-26-000010.md) | Quarterly report, period 2026-03-31 | 0001280776-26-000010 |
| 2026-04-28 | 07:00 ET | [8-K](/filings/0001193805-26-000516.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000516 |
| 2026-04-23 | 08:30 ET | [8-K](/filings/0001193805-26-000495.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000495 |
| 2026-04-22 | 16:56 ET | [10-K/A](/filings/0001193805-26-000493.md) | Annual report, amended, period 2025-12-31 | 0001193805-26-000493 |
| 2026-04-14 | 16:05 ET | [8-K](/filings/0001193805-26-000461.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193805-26-000461 |
| 2026-04-10 | 16:05 ET | [8-K](/filings/0001193805-26-000437.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-000437 |
| 2026-04-01 | 07:00 ET | [8-K](/filings/0001193805-26-000382.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000382 |
| 2026-03-31 | 06:45 ET | [8-K](/filings/0001193805-26-000370.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000370 |
| 2026-03-02 | 16:30 ET | [DEF 14A](/filings/0001193805-26-000201.md) | Proxy statement, period 2026-04-14 | 0001193805-26-000201 |
| 2026-02-26 | 07:16 ET | [10-K](/filings/0001280776-26-000005.md) | Annual report, period 2025-12-31 | 0001280776-26-000005 |
| 2026-02-26 | 07:00 ET | [8-K](/filings/0001193805-26-000181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000181 |
| 2026-02-20 | 18:59 ET | [SCHEDULE 13D](/filings/0000921895-26-000531.md) | Ownership report, active investor | 0000921895-26-000531 |
| 2026-02-13 | 07:00 ET | [8-K](/filings/0001193805-26-000129.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000129 |
| 2026-01-06 | 16:05 ET | [8-K](/filings/0001193805-26-000011.md) | 3.01 Delisting notice | 0001193805-26-000011 |
| 2026-01-05 | 17:00 ET | [8-K](/filings/0001193805-26-000007.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-000007 |
| 2025-11-13 | 07:26 ET | [8-K](/filings/0001193805-25-001570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001570 |
| 2025-11-13 | 07:17 ET | [10-Q](/filings/0001280776-25-000017.md) | Quarterly report, period 2025-09-30 | 0001280776-25-000017 |
| 2025-09-25 | 07:01 ET | [8-K](/filings/0001193805-25-001357.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001357 |
| 2025-08-07 | 06:58 ET | [10-Q](/filings/0001280776-25-000012.md) | Quarterly report, period 2025-06-30 | 0001280776-25-000012 |
| 2025-08-07 | 06:36 ET | [8-K](/filings/0001193805-25-001164.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001164 |
| 2025-07-11 | 17:01 ET | [8-K](/filings/0001193805-25-001008.md) | 5.02 Departure or appointment of officers or directors | 0001193805-25-001008 |
| 2025-06-27 | 17:15 ET | [8-K](/filings/0001193805-25-000943.md) | 3.01 Delisting notice | 0001193805-25-000943 |
| 2025-06-04 | 16:07 ET | [8-K](/filings/0001193805-25-000787.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-25-000787 |
| 2025-05-30 | 16:44 ET | [8-K](/filings/0001193805-25-000757.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000757 |
| 2025-05-28 | 16:13 ET | [8-K](/filings/0001193805-25-000730.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000730 |
| 2025-05-15 | 16:08 ET | [10-Q](/filings/0001280776-25-000008.md) | Quarterly report, period 2025-03-31 | 0001280776-25-000008 |
| 2025-04-30 | 07:37 ET | [8-K](/filings/0001193805-25-000582.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000582 |
| 2025-04-22 | 17:15 ET | [DEF 14A](/filings/0001193805-25-000541.md) | Proxy statement, period 2025-06-04 | 0001193805-25-000541 |
| 2025-04-09 | 17:26 ET | [8-K](/filings/0001193805-25-000454.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000454 |
| 2025-03-31 | 09:09 ET | [10-K](/filings/0001280776-25-000005.md) | Annual report, period 2024-12-31 | 0001280776-25-000005 |
| 2025-02-20 | 07:30 ET | [8-K](/filings/0001193805-25-000212.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000212 |
| 2025-01-13 | 08:32 ET | [8-K](/filings/0001193805-25-000038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000038 |
| 2024-12-18 | 16:36 ET | [8-K](/filings/0001193805-24-001496.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-24-001496 |
| 2024-11-07 | 07:04 ET | [10-Q](/filings/0001280776-24-000018.md) | Quarterly report, period 2024-09-30 | 0001280776-24-000018 |
| 2024-11-07 | 06:45 ET | [8-K](/filings/0001193805-24-001316.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001316 |
| 2024-10-22 | 06:45 ET | [8-K](/filings/0001193805-24-001257.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001257 |
| 2024-09-10 | 16:05 ET | [8-K](/filings/0001193805-24-001102.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001102 |
| 2024-09-03 | 08:30 ET | [8-K](/filings/0001193805-24-001079.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193805-24-001079 |

Page 1 of 6. [Older](/companies/imux/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 08:49 ET. No prices; not investment advice.